Provided by Tiger Trade Technology Pte. Ltd.

KINTOR PHARMA-B

3.000
-0.120-3.85%
Volume:7.51M
Turnover:22.04M
Market Cap:1.50B
PE:-8.32
High:3.250
Open:3.250
Low:2.800
Close:3.120
52wk High:4.700
52wk Low:1.050
Shares:499.00M
HK Float Shares:499.00M
Volume Ratio:0.68
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.361
ROE:-54.99%
ROA:-17.21%
PB:6.11
PE(LYR):-8.32
PS:120.14

Loading ...

OpenAI Explores New Revenue Streams in Pharma: Plans "Investment Plus Royalty" Model to Target AI-Driven Biotech Innovation

Stock News
·
Feb 04

32 New Funds Launched This Week: 27 Firms Including GF and E Fund Compete Across Battery, AI, Healthcare, and Gold Sectors, Some Products Already Closed Early

Deep News
·
Feb 03

Hubei Jumpcan Pharmaceutical (600566.SZ) Subsidiary Signs Exclusive Commercialization Agreement with Puqi Pharmaceutical

Stock News
·
Feb 02

KINTOR PHARMACEUTICAL LIMITED (09939) Announces Monthly Return as of January 31, 2026

Bulletin Express
·
Feb 02

283 Healthcare Stocks Preview 2025 Performance: Top Forecast Shows Over 32-Fold Increase, 39 Stocks Including Zhifei Biological Report First Loss

Deep News
·
Feb 01

New Stock Alert | Xinji Pharmaceutical, Yifei Technology Among Companies With Hong Kong IPO Applications Accepted by China Securities Regulatory Commission

Stock News
·
Jan 30

Yan'an Pharma's Second Attempt at BSE Listing: Strained Cash Flow, Persistent Margin Pressure, and Governance Concerns Draw Regulatory Scrutiny

Deep News
·
Jan 30

Renfu Pharmaceutical Claim Submission Filed for Registration, Eligible Investors Can Register

Deep News
·
Jan 30

Hong Kong Stock Movement | TYK MEDICINES-B (02410) Surges Over 13% in Morning Session as Aimdotinib Mesylate Tablets Included in Priority Review List

Stock News
·
Jan 30

TYK MEDICINES-B (02410) Has Its Investigational Class 1 New Drug, Aidosertinib Mesylate Tablets, Included in the CDE's Priority Review List

Stock News
·
Jan 29

China Galaxy Securities: Bullish on Pharma's Earnings Certainty, Innovation, and Overseas Expansion; Sector Poised for Rebound in 2026

Stock News
·
Jan 29

Over 10 Companies Queue for Hong Kong Listings, "A+H" Emerges as New Choice for Pharma IPOs - Why Are A-Share Drugmakers Flocking to HK?

Deep News
·
Jan 29

“Growth Stock Prodigy” Chen Jinwei’s Latest Views: China’s Chemical Industry Advantage Unshakable for a Decade, Most Bullish on Midstream Cyclicals and Consumer Healthcare

Deep News
·
Jan 29

New Share Alert | Okada Pharma Files for Hong Kong Listing

Stock News
·
Jan 27

Outbreak Alert! India Hit by Nipah Virus! 20% Surge Limit Hit, Pharmaceutical Stocks See Collective Movement!

Deep News
·
Jan 26

Xinbang Pharmaceutical: By End of 2024, Subsidiary Kekai Pharmacy Established Drug Retail Network Covering Existing and Major Partner Hospitals

Deep News
·
Jan 26

Kintor Pharmaceutical Chief Executive Boosts Holding

MT Newswires Live
·
Jan 26

Focus on Lightning-Fast Drug Delivery Services Accelerates Integrated Health Insurance and Pharmaceutical Ecosystem

Deep News
·
Jan 26

KINTOR PHARMA-B (09939) Receives 4.7 Million Share Purchase from Board Chairman Tong Youzhi

Stock News
·
Jan 26

BRIEF-Kintor Pharmaceutical Says Chairman Buys By 4.7 MLN Co Shares For HK$10.82 MLN From Nov 17, 2025 To Jan 23

Reuters
·
Jan 26